Evidence map›Paper›PMID 28854685›Full record

ArticleFEMS microbiology letters2017

Mutagenesis and expression of methane monooxygenase to alter regioselectivity with aromatic substrates.

Malcolm Lock, Tim Nichol, J Colin Murrell, Thomas J Smith

Open access · hybridAbstract read
In one paragraph

Article in FEMS microbiology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Research progress in bioremediation of petroleum pollution.Environmental science and pollution research international · 2021
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Malcolm LockBiomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
Tim NicholBiomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
J Colin MurrellSchool of Environmental Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Thomas J SmithBiomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
Sheffield Hallam University · GBUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C003276/1Biotechnology and Biological Sciences Research Council BB/F012713/1
6 · The paper itself

Abstract

Soluble methane monooxygenase (sMMO) from methane-oxidising bacteria can oxygenate more than 100 hydrocarbons and is one of the most catalytically versatile biological oxidation catalysts. Expression of recombinant sMMO has to date not been achieved in Escherichia coli and so an alternative expression system must be used to manipulate it genetically. Here we report substantial improvements to the previously described system for mutagenesis of sMMO and expression of recombinant enzymes in a methanotroph (Methylosinus trichosporium OB3b) expression system. This system has been utilised to make a number of new mutants and to engineer sMMO to increase its catalytic precision with a specific substrate whilst increasing activity by up to 6-fold. These results are the first 'proof-of-principle' experiments illustrating the feasibility of developing sMMO-derived catalysts for diverse applications.

Indexed as

MutagenesisBiocatalysisBiotechnologyMethaneMethylosinus trichosporiumMutationOxidation-ReductionOxygenasesProtein EngineeringRecombinant ProteinsSubstrate SpecificityMethanemethane monooxygenaseOxygenasesRecombinant Proteinsbiocatalysishydrocarbon oxidationmethanemonooxygenaseprotein engineering

Identifiers

PMID28854685
PMCPMC5812538
OpenAlexW2730956205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.